SEC Form D · filed August 8, 2016
Vyripharm Enterprises, L.L.C
Offering
$2.3M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗